CLINICAL_TRIALS
other
· 2025-09-25
Clinical Trial Update: Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy [Phase 2]
Summary
A Phase 2 study of Adebrelimab in combination with Apatinib for advanced hepatocellular carcinoma after prior systemic therapy is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Song Peng | Conditions: Hepatocellular Carcinoma Non-resectable | Phase 2 | Status: NOT_YET_RECRUITING